Biosafety Level-3 laboratories (BSL-3) are an essential part of research infrastructure and are used to develop vaccines and therapies. The research conducted in them provides insights into host-pathogen interactions that may help prevent future pandemics. However, these facilities also potentially pose a risk to society through lab accidents or misuse. Despite their importance, there is no comprehensive list of BSL-3 facilities, or the institutions in which they are housed. By systematically assessing PubMed articles published in English from 2006-2021, this paper maps institutions that host BSL-3 labs by their locations, augmenting current knowledge of where high-containment research is conducted globally.

CSET Senior Fellow Andrew Lohn testified before the House of Representatives Homeland Security Subcommittee on Cybersecurity, Infrastructure Protection, and Innovation at a hearing on "Securing the Future: Harnessing the Potential of Emerging Technologies While Mitigating Security Risks." Lohn discussed the application of AI systems in cybersecurity and AI’s vulnerabilities.

China is banking on applying AI to biotechnology research in order to transform itself into a “biotech superpower.” In pursuit of that goal, it has emphasized bringing together different aspects of the development cycle to foster multidisciplinary research. This data brief examines the emerging trend of co-location of AI and biotechnology researchers and explores the potential impact it will have on this growing field.

CSET Senior Fellow Andrew Lohn testified before the House of Representatives Science, Space and Technology Subcommittee on Investigations and Oversight and Subcommittee on Research and Technology at a hearing on "Securing the Digital Commons: Open-Source Software Cybersecurity." Lohn discussed how the United States can maximize sharing within the artificial intelligence community while reducing risks to the AI supply chain.

CSET Senior Fellow Andrew Lohn testified before the U.S. Senate Armed Services Subcommittee on Cybersecurity hearing on artificial intelligence applications to operations in cyberspace. Lohn discussed AI's capabilities and vulnerabilities in cyber defenses and offenses.

CSET Research Fellow Caroline Schuerger testified before the Bipartisan Commission on Biodefense hearing on "The Biological Threat Expanse" Current and Future Challenges to National Biodefense." She discussed threats to the bioeconomy and steps the U.S. and its allies can take to harness biotechnology's capabilities and raise awareness of risky research.

CSET submitted this comment to the Department of Commerce to inform incentives, infrastructure, and research and development needed to support a strong domestic semiconductor industry.

Created through a joint partnership between CSET and the AI Education Project, the AI Education Catalog aims to raise awareness of the AI-related programs available to students and educators, as well as to help inform AI education and workforce policy.

CSET submitted this comment to the Office of Science and Technology Policy and the National Science Foundation to support the work of the National Artificial Intelligence Research Resource (NAIRR) Task Force to develop an implementation roadmap that would provide AI researchers and students across scientific disciplines access to computational resources, high-quality data, educational tools, and user support.

China wants to be a “cyber powerhouse” (网络强国). At the heart of this mission is the sprawling 40 km2 campus of the National Cybersecurity Center. Formally called the National Cybersecurity Talent and Innovation Base (国家网络安全人才与创新基地), the NCC is being built in Wuhan. The campus, which China began constructing in 2017 and is still building, includes seven centers for research, talent cultivation, and entrepreneurship; two government-focused laboratories; and a National Cybersecurity School.